New drug cocktail aims to stop triple negative breast cancer from returning
NCT ID NCT07679360
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This Phase 3 trial tests whether a combination of two drugs, trastuzumab rezetecan and adebrelimab, can prevent breast cancer from returning in people with triple negative breast cancer who still have cancer cells after initial chemotherapy and surgery. The study compares this new combination to standard treatments chosen by the doctor. About 1000 participants will be randomly assigned to receive either the experimental combination or a standard therapy, and researchers will track how long they live without the cancer coming back.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Trastuzumab Rezetecan and Adebrelimab
- What this could lead to
- If successful, this combination could offer a more effective treatment option for triple negative breast cancer patients who still have cancer after initial therapy, potentially reducing the risk of recurrence.
- What could go wrong
- This is an early-stage Phase 3 trial, and the combination may not prove more effective than existing treatments. Side effects from the drugs could be significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Hospital of Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a High-Fiber diet shield the gut during breast cancer therapy?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Can a Two-Pronged antibody boost Chemo's power against a tough breast cancer?
- Can a new drug rally the immune system against Hard-to-Treat cancers?
- Could an oral chemo pill improve breast cancer treatment?
- Can a new nucleotide analogue boost cancer treatment?